• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NGM
    16.75 Down 0.21(1.24%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Net Income 917   4,355   27,858   3,201  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation588  718  753  746  
    Adjustments To Net Income3,173  (120)768  13  
    Changes In Accounts Receivables(2,001)(1,957)(4,446)(1,142)
    Changes In Liabilities(1,951)6,192  3,134  (7,268)
    Changes In Inventories(261)(2,296)(1,044)(2,144)
    Changes In Other Operating Activities38  102  (240)(346)
    Total Cash Flow From Operating Activities 503   6,994   26,783   (6,940)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(189)(118)(94)(118)
    Investments(8,584)(7,210)230  7,501  
    Other Cash flows from Investing Activities(2,463)(1,356)(1,109)(984)
    Total Cash Flows From Investing Activities (11,236) (8,684) (973) 6,399  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock147  306  14  245  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 147   306   14   245  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (10,586) (1,384) 25,824   (296)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.